184 related articles for article (PubMed ID: 9369972)
1. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
Bischofberger N; Jacobson KA; von Lubitz DK
Ann N Y Acad Sci; 1997 Oct; 825():23-9. PubMed ID: 9369972
[No Abstract] [Full Text] [Related]
2. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.
Heurteaux C; Lauritzen I; Widmann C; Lazdunski M
Proc Natl Acad Sci U S A; 1995 May; 92(10):4666-70. PubMed ID: 7753861
[TBL] [Abstract][Full Text] [Related]
3. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
Von Lubitz DK
Eur J Pharmacol; 1999 Jan; 365(1):9-25. PubMed ID: 9988118
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptors and neuroprotection.
Ongini E; Adami M; Ferri C; Bertorelli R
Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
[TBL] [Abstract][Full Text] [Related]
5. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Abbracchio MP; Cattabeni F
Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
[TBL] [Abstract][Full Text] [Related]
6. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
von Lubitz DK
Eur J Pharmacol; 1999 Apr; 371(1):85-102. PubMed ID: 10355598
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A3 receptor stimulation and cerebral ischemia.
Von Lubitz DK; Lin RC; Popik P; Carter MF; Jacobson KA
Eur J Pharmacol; 1994 Sep; 263(1-2):59-67. PubMed ID: 7821362
[TBL] [Abstract][Full Text] [Related]
8. [Comparative characteristics of A1-receptor agonists as neuroprotective agents].
Kulinskiĭ VI; Minakina LN; Usov LA
Eksp Klin Farmakol; 2001; 64(5):19-22. PubMed ID: 11764492
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential for adenosine receptor activation in ischemic brain injury.
Miller LP; Hsu C
J Neurotrauma; 1992 May; 9 Suppl 2():S563-77. PubMed ID: 1613814
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A1 receptor activation preferentially protects cultured cerebellar neurons versus astrocytes against hypoxia-induced death.
Logan M; Sweeney MI
Mol Chem Neuropathol; 1997 Jun; 31(2):119-33. PubMed ID: 9376019
[TBL] [Abstract][Full Text] [Related]
11. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
Von Lubitz DK; Beenhakker M; Lin RC; Carter MF; Paul IA; Bischofberger N; Jacobson KA
Eur J Pharmacol; 1996 Apr; 302(1-3):43-8. PubMed ID: 8790990
[TBL] [Abstract][Full Text] [Related]
12. [The comparative characteristics and receptor mechanism of the effect of adenosine-receptor agonists in total cerebral ischemia].
Kulinskiĭ VI; Usov LA; Sufianova GZ; Lidak MIu; Iurkevich AM
Eksp Klin Farmakol; 1993; 56(6):13-6. PubMed ID: 8111286
[TBL] [Abstract][Full Text] [Related]
13. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
Abbracchio MP; Ceruti S; Brambilla R; Franceschi C; Malorni W; Jacobson KA; von Lubitz DK; Cattabeni F
Ann N Y Acad Sci; 1997 Oct; 825():11-22. PubMed ID: 9369971
[No Abstract] [Full Text] [Related]
14. Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
Von Lubitz DK; Lin RC; Jacobson KA
Eur J Pharmacol; 1995 Dec; 287(3):295-302. PubMed ID: 8991804
[TBL] [Abstract][Full Text] [Related]
15. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.
Von Lubitz DK; Lin RC; Bischofberger N; Beenhakker M; Boyd M; Lipartowska R; Jacobson KA
Eur J Pharmacol; 1999 Mar; 369(3):313-7. PubMed ID: 10225368
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclopentyladenosine on lipid peroxidation during focal cerebral ischemia.
Sufianova GZ; Sufianov AA; Shapkin AG
Bull Exp Biol Med; 2014 Jun; 157(2):228-30. PubMed ID: 24952491
[TBL] [Abstract][Full Text] [Related]
17. Lack of central effects of peripherally administered adenosine A(1) agonists on synaptic transmission in the rat hippocampus.
Gervitz LM; Lutherer LO; Hamilton ME; Fowler JC
Brain Res; 2002 Sep; 951(1):141-5. PubMed ID: 12231468
[TBL] [Abstract][Full Text] [Related]
18. [The effect of adenosine receptor agonists on the normal cerebral blood flow and in subsequent ischemia].
Kulinskiĭ VI; Sufianova GZ; Usov LA; Ekimov EN
Eksp Klin Farmakol; 1996; 59(3):37-9. PubMed ID: 8974582
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity.
Sweeney MI
Neurosci Biobehav Rev; 1997 Mar; 21(2):207-17. PubMed ID: 9062944
[TBL] [Abstract][Full Text] [Related]
20. Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat.
Dora CD; Koch S; Sanchez A; Ruenes G; Liu S; Yezierski RP
J Neurotrauma; 1998 Jul; 15(7):473-83. PubMed ID: 9674551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
